Erika Hamilton: Delphi Consensus on the Prevention and Treatment of Stomatitis with datoDXd
Erika Hamilton, Chair of the Executive Committee, Breast and Breast Program Lead at Sarah Cannon Research Institute, shared a post on LinkedIn about a paper she co-authored with colleagues published in Supportive Care in Cancer:
“One of the advantages, and responsibilities, of clinical trial participation is using that experience and learnings to teach others how to best manage side effects for patients once the drug is commercially available.
Happy to participate in this Delphi consensus statement on the prevention and treatment of stomatitis with datoDXd.”
Title: US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan
Authors: Hope Rugo, Aditya Bardia, Debora S. Bruno, Vinicius Ernani, Erika Hamilton, Rebecca Heist, Komal Jhaveri, Benjamin Levy, Aaron Lisberg, Joyce O’Shaughnessy, Jacob Sands, Alexander Spira, Sara Tolaney, Nathaniel S. Treister, Cecile Matthews, Melissa Johnson
You can read the Full Article on Supportive Care in Cancer.
More posts featuring Erika Hamilton.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023